9 months ago
ZVRA
AnalystsEddie HickmanEddie Hickman's Stock Forecasts
AnalystsEddie Hickman
Sectors:
Industries:
Analyst Ranking
Top 7%
#355 out of 5115 analysts
Average Return
+212.87%
Win Rate
73%11 out of 15
Risk vs Reward
Poor
Good
Eddie Hickman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Promis Neurosciences IncPMN | +1,910.28% | $0.36 | $7.24 | 2025-11-17 - 2025-11-26 | Strong Buy |
Promis Neurosciences IncPMN | +858.54% | $0.76 | $7.24 | 2025-03-31 - 2025-11-26 | Strong Buy |
Iveric Bio IncISEE | +167.40% | $14.94 | $39.95 | 2022-09-06 - 2023-07-10 | Strong Buy |
Tarsus Pharmaceuticals IncTARS | +89.14% | $42.56 | $80.50 | 2025-02-25 - 2025-11-26 | Strong Buy |
Tarsus Pharmaceuticals IncTARS | +85.16% | $16.98 | $31.44 | 2023-09-10 - 2024-09-10 | Strong Buy |
Eddie Hickman Analyst Color
Get additional color on Eddie Hickman's coverage of popular stocks
Eddie Hickman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Promis Neurosciences IncPMN | 2 | Strong Buy | $125.00 | +1,627.24% | Maintains | 10 days ago |
Tarsus Pharmaceuticals IncTARS | 6 | Strong Buy | $87.00 | +8.07% | Maintains | 23 days ago |
Zevra Therapeutics IncZVRA | 1 | Strong Buy | $22.00 | +155.81% | Maintains | 9 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $32.00 | +116.95% | Initiates Coverage On | 9 months ago |
Cybin IncCYBN | 1 | Strong Buy | $35.00 | +480.43% | Initiates Coverage On | 9 months ago |
Outlook Therapeutics IncOTLK | 3 | Strong Buy | $12.00 | +614.29% | Reiterates | 10 months ago |
Iveric Bio IncISEE | 1 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.